Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

120.67 -3.68 (-2.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,717,826
Open 124.08
Bid (Size) 120.26 (100)
Ask (Size) 121.40 (200)
Prev. Close 124.35
Today's Range 119.93 - 125.11
52wk Range 88.57 - 128.70
Shares Outstanding 1,253,809,440
Dividend Yield 2.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
As the pharmaceutical industry rings in 2026, the landscape of healthcare investment has shifted from cautious recovery to a full-scale acquisition frenzy. Driven by a looming "super-cliff" of patent... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q3 Earnings?
Gilead Sciences trades at $117.95 and has moved in lockstep with the market. Its shares have returned 5.5% over the last six months while the S&P 500 has gained 10.1%. 
Via StockStory
Topics Stocks

Performance

YTD
-0.8%
-0.8%
1 Month
+1.1%
+1.1%
3 Month
+3.4%
+3.4%
6 Month
+5.4%
+5.4%
1 Year
+35.4%
+35.4%

More News

Read More
News headline image
U.S. Scales Back The Number Of Vaccines It Recommends For Every Child ↗
Via Stocktwits
Topics Government
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs ↗
Via Stocktwits
News headline image
3 Cash-Flow Machines Investors May Want Heading Into 2026 ↗
Via MarketBeat
News headline image
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today ↗
Via Benzinga
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
What's Driving the Market Sentiment Around Gilead Sciences Inc? ↗
Via Benzinga
News headline image
Stock Index Futures Slip in Weak End to a Banner Year
Via Barchart.com
Topics Bonds Government Stocks
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
GILEAD SCIENCES INC (NASDAQ:GILD) Shows High Technical and Setup Ratings for a Potential Breakout ↗
Via Chartmill
News headline image
Jobless Claims Unexpectedly Fall For Second Consecutive Week ↗
Via Stocktwits
Topics Stocks
News headline image
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million ↗
Via Benzinga
News headline image
RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug ↗
Via Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
Via Stocktwits
Topics Government
News headline image
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Gilead Sciences to Present at Upcoming Investor Conference
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes ↗
Via Benzinga
News headline image
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal ↗
Via Benzinga
Topics Government
News headline image
Why Gilead Sciences (GILD) Stock Is Up Today
Via StockStory
Topics Earnings
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
Via Stocktwits
Topics Government World Trade
News headline image
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗
Via Investor's Business Daily
Topics Government Stocks
News headline image
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
From Gilead Sciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 120.67
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 01/08/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 151.30B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 151B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.